Rare diseases
Investigational molecules
Locations
Back to Italy23 clinical trials in Cosenza, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
ItalyRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
ItalyStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
ItalyTreatment Study of Arsenic Trioxide, Tretinoin, and Gemtuzumab Ozogamicin for Children and Adolescents with Acute Promyelocytic Leukemia
ItalyStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
ItalyStudy of chemotherapy with blinatumomab and tyrosine kinase inhibitors in newly diagnosed children and young adults with Philadelphia chromosome positive B-cell acute lymphoblastic leukemia
ItalyStudy Comparing Single and Dual Antiplatelet Therapy with Clopidogrel and Acetylsalicylic Acid in Elderly Patients or Those at Risk of Bleeding After Balloon Surgery
ItalyStudy on Luspatercept for Treating Anemia in Patients with Myelodysplastic Syndromes (MDS) with del5q, Resistant to Prior Treatments and Needing Blood Transfusions
ItalyStudy of Ibrutinib for Treating Autoimmune Hemolytic Anemia in Patients with Chronic Lymphocytic Leukemia or Similar Conditions
ItalyStudy of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma
ItalyStudy of Teclistamab and Lenalidomide as Maintenance Treatment for Newly Diagnosed Multiple Myeloma Patients After Stem Cell Transplantation
ItalyStudy of venetoclax, obinutuzumab and zanubrutinib combination therapy in young patients with high-risk Chronic Lymphocytic Leukemia and residual disease
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on multiple myeloma treatments, including novel combinations of therapies for newly diagnosed patients. Studies evaluating carfilzomib with different drug combinations and maintenance strategies.
Advanced clinical trials investigating treatment outcomes and long-term disease management.
Innovative studies targeting various forms of leukemia, including chronic lymphocytic leukemia and chronic myeloid leukemia. Research focuses on targeted therapies and treatment optimization.
Emphasis on developing personalized treatment approaches for different patient populations.
Comprehensive research on rhabdomyosarcoma in both children and adults, exploring various treatment phases and therapeutic combinations.
Integration of novel therapeutic approaches for improved patient outcomes.
Innovative research addressing chronic kidney disease, investigating various therapeutic agents to slow disease progression and improve patient outcomes.
Focus on developing effective interventions for long-term disease management.
Advanced research on venous thromboembolism in cancer patients, comparing various anticoagulation strategies and treatment approaches.
Evaluation of novel therapeutic agents for improved patient care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
